healthcare diagnostics News
-
“Rapid Cycle” improvement to diagnostic services utilization - healthcare management forum
TOPIC: Update on eHealth in Ontario: What’s Next? Plenary Session 4 at Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Monday, April 4 2011 at 1:30 p.m WHERE: Toronto Priority Code: 3BL1 Featuring: Phillip P. Morehouse, Director, Health Transformation, Cape Breton District Health Authority Evidence-based decision-making and knowledge transfer are critical ...
By 3BL Media
-
HORIBA Medical welcomes the latest member of the new Yumizen H500 family
As a result of a growing research and development program, HORIBA Medical has recently developed two new products that aim to better meet the needs of today's clinical laboratories : The Yumizen H500 OT ‘Open Tube’ with flexible sampling to accommodate all sample types, particularly for rapid screening in critical care, emergency care and pediatric clinics. The new released ...
-
Showcase
PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear
Champaign, Ill. – Jan. 6, 2020 – PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing healthcare providers with better diagnostic tools, today announced that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for its TOMi™ Scope [OtoSight Middle Ear Scope] for non-invasive imaging of the middle ear. Using optical coherence ...
-
Edinburgh Molecular Imaging Ltd appoints new Chairman
The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE ...
-
Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American Medical Device Summit: Location: Westin Chicago ...
-
Clip Health™ Expands Company Leadership to Support Innovation Pipeline in Diagnostics-Enabled Decentralized Healthcare
Clip Health, a pioneer in the development of accessible and accurate diagnostics, has made two skilled additions to its leadership team. To continue innovating towards the Company’s product vision of diagnostics-enabled “full stack” healthcare, Clip Health welcomes Maria-Nefeli Tsaloglou, PhD as Vice President of Assay & Product Development, and Cynthia Merrell as Vice ...
By Clip Health
-
Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board
We are pleased to announce that famed American Geneticist George Church will be joining Alveo’s Scientific Advisory Board. With extensive background in medical diagnostics, including founding application-based companies, George will bring valuable expertise to our Board as we continue to grow and democratize our healthcare system. “At Alveo, we are focused on intercepting the spread ...
-
Eg Technology Launch Free Diagnostics EBook And Supporting Gap Analysis
The free eBook has been created as a tool to help organisations identify common areas of concern within any diagnostics development programme and help create a refined development roadmap, ensuring complete end-to-end project visibility and a streamlined route to market. The Covid 19 pandemic has had a noticeable impact on the MedTech landscape, specifically within the field of diagnostics. As ...
-
Why we Started (TBT): HIV Testing
Why HIV Testing is Important HIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once, and individuals deemed high risk should be tested more frequently. A positive test allows individuals to then seek treatment (there are several forms of effective treatment currently available) and prevent transmission to others. How HIV Testing ...
By Fluxergy
-
Baymatob Builds Executive Team for Next-Stage Milestones and Growth
Baymatob™, a pioneer in women’s health and AI-guided monitoring for maternity and child birth, is excited to announce the appointment of Dr Sarah McDonald as Chair of the Board, Tara Croft as Chief Executive Officer, and Tony Barclay as Acting Chief Financial Officer. Sarah is the founder of Baymatob and as CEO has worked to establish and grow the company over the last eight years. ...
-
20 Healthtech Innovations to watch in 2022
HiberGene Diagnostics are delighted to be recognised as one of Irelands ‘20 Healthtech innovations to watch in 2022’. Thanks to the support from the Health Innovation Hub Ireland, HiberGene were able to work with Bon Secours Health System Ireland, Cork in carrying out a very successful clinical evaluation of its PCR Adapt Covid-19 test, with excellent results. Clinical Need The ...
-
2019 ATS/ERS Spirometry Standard - Now available on EasyOne Air, EasyOne Pro/LAB, and Easy on-PC
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has updated the entire EasyOne® product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019. Spirometry is widely used in the ...
-
BioSerenity, Inc. appoints new leadership in North America
BioSerenity, a high-growth company specializing in research and remote diagnostic solutions for neurology, sleep medicine, and cardiology, announces Jeff Wren’s appointment as Chief Executive Officer of North America. Jeff Wren assumes the leadership role in the states as Pierre Frouin, CEO of BioSerenity, moves back to Europe. Since its expansion to the United States in 2019, ...
By BioSerenity
-
Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans in Drug Discovery and Development, Data Science, and Business Development
Juvena Therapeutics, Inc. (“Juvena”), a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, announced today the hiring of four senior leaders with significant industry experience in both small and large pharmaceutical and biotech companies. The company plans to continue growing its team to power the expansion of Juvena’s ...
-
Extraction-free PCR testing for SARS-CoV-2
The OPTI SARS-CoV-2 RT-PCR Test has received FDA Emergency Use Authorization and CE-IVD for sample handling using the OPTI Rapid Lysis Buffer. The OPTI Rapid Lysis Buffer protocol eliminates the need for magnetic bead or spin column extraction and prepares the samples for PCR testing using a simple heating protocol. The OPTI Rapid Lysis Buffer has shown a diagnostic sensitivity and specificity of ...
-
Aurora BioPharma to Attend the Oppenheimer & Co. 27th Annual Healthcare Conference at the Westin New York Grand Central in New York City
Aurora BioPharma, Inc., a clinical stage biotechnology company developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and President, Robert Brooks, will attend the Oppenheimer & Co. 27th Annual Healthcare Conference on March 21-22, 2017 at The Westin New York Grand Central in New York City. The event is one of the most important investor conferences ...
-
How portable diagnostic readers are changing the future for patient care
There are numerous ways to provide quality diagnosis and preventative care. One of them is by investing in portable scanners, adopting huge benefits for improved healthcare procedures. What is a portable diagnostic reader? Usually a handheld device, measuring health parameters and helping to diagnose a patient using smart algorithms from a chosen assay. At AgPlus, The Agilis Reader works in ...
-
Intrasense signs a historic contract with Brazilian medical technology leader MV
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina. Intrasense solutions gain strong visibility in Latin America MV, a leading provider of ...
By Intrasense
-
Critical Diagnostics Inks Exclusive Worldwide License Agreement for New Heart Failure Biomarker sNEP
Critical Diagnostics announced today that it entered into a license agreement for the exclusive worldwide rights to the use of the biomarker soluble neprilysin (sNEP) in the diagnosis and monitoring of heart failure patients. Health Sciences Research Institute Germans Trias i Pujol Foundation (IGTP) of Barcelona Spain is the licensor. The neprilysin inhibitor Sacubitril is a key ingredient in a ...
-
Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022. The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you